1Kiesseier BC,Tani M,Mahad D,et al. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies[J]. a central role for P10. Brain, 2002,125(Pt4) :823.
4Willisori Hj, O Hanlon GM, Paterson G, et al. Mechanism ofaction of anti-GM1 and anti-GQlb ganglioside antibodies in Guillain-Barre syndrome[J]. Infectious Disease,2003,176(supp12):144.
5Van Schaik IN,Bossuyt PMM,Brand A,et al. Diagnostic value of GM1 anti-bodies in motor neuron disorders and neuropathies: a mata-analysis[J]. Neurology, 2005,45: 1570.
6Fredman P, Vedeler CA, Nyland H, et al. Antibodies on sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin[J]. Neurol, 2001,238 : 75.
7Maimone D, Annuniata P, Simone IL, et al. Interleukin-6 and serumof patientswith Guillain-Barre syhdrome and chronic inflammatoey demyelination polyradiculoneuropathy[J]. Journal of Neuroimmunology, 2003,47 : 55.
8Weeller M,Stevens A,Sommer N,et al. Comparative analysis of cytokine patterns in immunological, infee-tious and oncological disorders[J]. J of Neurolo Sci,2001,104 : 215.
9Shimada K,Koh CS, Yanagisawa N. Detection of interleukin-6 in serum and cerebrospinal fluid of patients with neuroimmunological diseases[J]. Arergi, 2003,42 (8) : 934.
